Low-level inotropic stimulation with type III phosphodiesterase inhibitors in patients with advanced symptomatic chronic heart failure receiving β-blocking agents
Authors:
- Simon F. ShakarSSSimon F. Shakar
- Michael R. BristowMBMichael R. Bristow
- 1 May 2001
- journal article
- research article
- Published by Springer Nature in Current Cardiology Reports
- Vol. 3 (3) , 224-231
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Myocardial-Directed Overexpression of the Human β1-Adrenergic Receptor in Transgenic MiceJournal of Molecular and Cellular Cardiology, 2000
- Effects of metoprolol on myocardial β-adrenoceptors and G iα -proteins in patients with congestive heart failureEuropean Journal of Clinical Pharmacology, 1996
- A sustained increase in β-adrenoceptors during long-term therapy with metoprolol and bisoprolol in patients with heart failure from idiopathic dilated cardiomyopathyLife Sciences, 1996
- Adverse consequences of high sympathetic nervous activity in the failing human heartJACC, 1995
- Changes in myocardial and vascular receptors in heart failureJACC, 1993
- Effect of enoximone alone and in combination with metoprolol on myocardial function and energetics in severe congestive heart failure: Improvement in hemodynamic and metabolic profileCardiovascular Drugs and Therapy, 1993
- Alpha- and Beta-Adrenergic Stimulation of Protein Synthesis in Cultured Adult Ventricular CardiomyocytesJournal of Molecular and Cellular Cardiology, 1993
- Enhancement of the effectiveness of milrinone to increase force of contraction by stimulation of cardiac beta-adrenoceptors in the failing human heartJournal of Molecular Medicine, 1988
- Cardiac energetics after intravenous enoximone in idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1987
- $beta;-Adrenergic function in heart muscle disease and heart failureJournal of Molecular and Cellular Cardiology, 1985